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Abstract
A decrease in the abundance and biodiversity of intestinal bacteria within the Firmicutes
phylum has been associated with inflammatory bowel disease (IBD). In particular, the anti-
inflammatory bacterium Faecalibacterium prausnitzii, member of the Firmicutes phylum and
one of the most abundant species in healthy human colon, is underrepresented in the micro-
biota of IBD patients. The aim of this study was to investigate the immunomodulatory prop-
erties of F. prausnitzii strain A2-165, the biofilm forming strain HTF-F and the extracellular
polymeric matrix (EPM) isolated from strain HTF-F. For this purpose, the immunomodulato-
ry properties of the F. prausnitzii strains and the EPM were studied in vitro using human
monocyte-derived dendritic cells. Then, the capacity of the F. prausnitzii strains and the
EPM of HTF-F to suppress inflammation was assessed in vivo in the mouse dextran sodium
sulphate (DSS) colitis model. The F. prausnitzii strains and the EPM had anti-inflammatory
effects on the clinical parameters measured in the DSS model but with different efficacy.
The immunomodulatory effects of the EPM were mediated through the TLR2-dependent
modulation of IL-12 and IL-10 cytokine production in antigen presenting cells, suggesting
that it contributes to the anti-inflammatory potency of F. prausnitzii HTF-F. The results show
that F. prausnitzii HTF-F and its EPMmay have a therapeutic use in IBD.
Introduction
Ulcerative colitis (UC) and Crohn’s disease (CD), two forms of inflammatory bowel disease
(IBD), are driven by an aberrant inflammatory T cell response to intestinal microbiota in a ge-
netically susceptible host. Profound changes in the diversity and composition of the microbiota
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are associated with UC and CD [1,2]. A decrease in the frequency of the phyla Bacteroidetes
and Firmicutes and an increase of Proteobacteria and Actinobacteria have been observed in the
faecal microbiota of IBD patients [3]. In particular, Faecalibacterium prausnitzii, a member of
the Firmicutes phylum and one of the most abundant species in the healthy human colon [4],
is underrepresented in the microbiota of IBD patients [5]. Mucosal-associated counts of F.
prausnitzii from ileal biopsies are also lower in CD patients with active disease than in patients
in remission [6,7]. F. prausnitzii was reported to be an anti-inflammatory bacterium on ac-
count of its capacity to induce high amounts of IL-10 in human peripheral blood mononuclear
cells (PBMCs, [7]). Treatment of Caco2 cells with F. prausnitzii culture supernatant was re-
ported to reduce IL-1β-induced NF-κB activation and secretion of IL-8. This was attributed
to an as yet unidentified factor secreted in the culture medium as it was not observed using
40 mM butyrate, UV-Killed bacteria or bacterial DNA, membranes and cytoplasmic extract
[7]. Administration of F. prausnitzii strain A2-165 and its culture supernatant have been
shown to protect against 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced colitis in mice [7].
This model is thought to resemble CD because the resulting mucosal inflammation is mediated
by a T helper 1 (Th1) response with excessive production of IFN-γ, TNF-α and IL-12. Addi-
tionally, intragastric administration of F. prausnitzii A2-165 and its culture supernatant have a
protective effect against dinitrobenzenesulfonic (DNBS)-induced chronic colitis [6].
The aim of this study was to test the capacity of two different F. prausnitzii strains to sup-
press inflammation in the mouse dextran sodium sulphate (DSS) colitis model. The strains
tested were A2-165 and the newly characterized HTF-F. Here we showed that strain HTF-F
produces an extracellular polymeric matrix (EPM) that might provide an advantage to coloni-
zation in vivo through intercellular aggregation and biofilm formation. As bacterial EPMs are
common components of biofilm matrices and have been previously shown to have immuno-
modulatory effects [8–10], we tested the EPM of strain HTF-F for its potential anti-inflamma-
tory effects in the DSS colitis model. Additionally, the immunomodulatory effects of the EPM
were investigated using immature dendritic cells derived ex vivo from human monocytes and
mouse bone marrow cells.
Materials and Methods
Animals
BALB/c mice were reared in conventional conditions. Two-month-old females were used for
these studies and their body weights were measured before and after each experiment. Animal
experiments were approved by the Ethical Committee of the Institute of Microbiology, Acade-
my of Sciences of the Czech Republic.
Bacterial strains and culturing conditions
F. prausnitzii strain HTF-F and A2-165 have been described elsewhere [11–13] and were main-
tained at 37°C on yeast extract, casitone, fatty acid and glucose medium (YCFAG, described in
[13]) under anaerobic conditions. For EPM production, F. prausnitzii strains were cultured in
YCAG broth, which have the same composition as YCFAG medium but, except acetate, all
short chain fatty acids were omitted. L. plantarumWCFS1 was cultured overnight until station-
ary phase in MRS broth (Merck, Darmstadt, Germany) at 37°C. Bacteria were harvested by
centrifugation at 4°C, 3300 g for 15 min, washed in PBS, resuspended in PBS containing 20%
glycerol and stored at -80°C prior to use. For the BMDCs assays, L. plantarumWCFS1 grown
in MRS at 37°C overnight were inactivated with 1% formaldehyde-PBS as described previously
[14]. Bacteria were quantified by fluorescent in situ hybridization (FISH) or phase contrast
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microscopy. All buffers and media used for the anaerobic bacteria were deoxygenated by flush-
ing with oxygen free nitrogen for 30 minutes.
Isolation and staining of the F. prausnitzii extracellular polymeric matrix
The cell bound EPM was extracted as previously described [15]. Briefly, 250 ml of 24 h cultures
of F. prausnitzii strains HTF-F or A2-165 were recovered by centrifugation at 18400 g for
10 min (4°C). The pre-washed cell pellet was suspended in 8 ml of PBS by vortexing for 5 min
allowing the cell bound EPM to dissolve. Planktonic cells were subsequently pelleted by centri-
fugation at 18400 g for 10 min (4°C). The supernatant was then carefully removed and added
to 4 volumes of ice cold absolute ethanol to precipitate the EPM. After centrifugation at 3300 g
for 30 min, the EPM precipitated pellet was washed with 70% ethanol, then lyophilized and
stored at -20°C. For further experiments, lyophilized EPM fractions were dissolved in PBS at
the desired concentrations. The EPM yield was 1.2 mg/ml from approximately 2.5 x 1011 bacte-
ria. The EPM was shown to be free of bacterial contamination by visual inspection after Gram
staining. TLR assays (described in S1 Materials and Methods) showed that the EPM was free of
contaminating microbe-associated molecular patterns (MAMPs).
Human DCs assays
This study was approved by Wageningen University Ethical Committee and was performed ac-
cording to the principles of the Declaration of Helsinki. Buffy coats from blood donors were
obtained from the Sanquin Blood bank in Nijmegen (The Netherlands). A written informed
consent was obtained before sample collection. The expression of surface markers and the cyto-
kines secreted in the supernatant were measured after incubation of hDCs with F. prausnitzii
A2-165 (hDCs from 3 donors), HTF-F (3 donors), L. plantarum (5 donors), EPM (3 donors)
or L. plantarum together with EPM (5 donors). Bacteria were used at a bacterium: DC ratio of
10:1 and the EPM at 14.4 μg/ml (1.2% v/v). Mononuclear cells were isolated from buffy coats
of healthy donors using Ficoll Paque Plus density gradient (GE Healthcare, Diegem, Belgium)
according to the manufacturer’s protocol. After centrifugation, mononuclear cells were collect-
ed and monocytes were isolated by positive selection of CD14+ cells using CD14-specific anti-
body coated magnetic microbeads (Miltentyi Biotec, Leiden, The Netherlands). CD14+ cells
were cultured for 6 days in complete medium in the presence of IL-4 and granulocyte-macro-
phage colony-stimulating factor (GMCFS, R&D Systems, Minneapolis, MN) to differentiate
into immature monocyte-derived DCs. At day 6, cells were seeded at 106 cells/ well in 24-well
plates and were treated with L. plantarum (bacterium: DC, 10:1) in the presence or absence of
the EPM isolated from F. prausnitzii (1,2% v/v) or left untreated. After 48 hours of co-incuba-
tion, the supernatant was collected for cytokine measurements. During the culture period and
the stimulation, DCs were cultured in RPMI 1640 culture medium (Invitrogen) supplemented
with 10% FCS, 100 U/ml penicillin and 100 μg/ml streptomycin (Sigma, St. Louis, MO) and no
bacterial growth was observed. On day 6 and 8, the activation and maturation status of the
CD14+ cells were assessed by measuring CD83 and CD86 surface expression and the cell viabil-
ity was measured using Annexin V and propidium iodide (PI). Cells were stained with fluores-
cence conjugated monoclonal antibodies specific for CD83, CD86, their isotype-matched
controls and with annexin V and PI (BD Biosciences, Breda, The Netherlands) and analysed
on a flow cytometer (FACS Canto II, BD). CD86 and CD83 were expressed at low levels on im-
mature or untreated DCs and were highly expressed after stimulation. On days 6 and 8 the via-
bility of the cells was between 60–80% (not shown).
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RNA isolation and real-time qPCR
Total RNA was isolated from hDCs using the RNAeasy Mini Kit (Qiagen) following the manu-
facturer instructions. cDNA synthesis was performed using 500 ng of isolated total RNA and
Q-script (Quanta bioscience) according to the manufacturer instructions. cDNA was diluted in
nuclease-free water to a final volume of 100 μl and stored at -20°C until further use. Primers
for IL-10 (forward 5’-GTGATGCCCCAAGCTGAGA-3’, reverse 5’-CACGGCCTTGCTC
TTGTTTT-3’), IL-12p40 (forward 5’-CTCTGGCAAAACCCTGACC-3’, reverse 5’-GCTTA
GAACCTCGCCTCCTT-3’), IL-1β (forward 5’-GTGGCAATGAGGATGACTTGTTC-3’, re-
verse 5’-TAGTGGTGGTCGGAGATTCGTA-3’), TNF-α (forward 5’- CTGCTGCAC
TTTGGAGTGAT-3’, reverse 5’-AGATGATCTGACTGCCTGGG-3’), and the reference genes
GAPDH (forward 5’-CTGCACCACCAACTGCTTAG-3’, reverse 5’-GTCTTCTGGGTGGC
AGTGAT-3’) and β-actin (forward 5’-TTGCGTTACACCCTTTCTTG-3’, reverse 5’-CACC
TTCACCGTTCCAGTTT-3’) were designed using PRIMER3 software [16]. Quantitative
RT-PCR (qPCR) was performed using the GoTaq qPCR mastermix (Promega), briefly, 5 μl
cDNA (20x dilution), forward and reverse primers (300 nM each) were added to 7 μl qPCR
mastermix and demineralised water was added to a final volume of 14 μl. The qPCR reaction
was carried out on a Rotorgene 6000 real-time cycler (Qiagen). Raw data were analysed using
the comparative quantitation method of the Rotor-gene Analysis Software V5.0 and relative
gene expression levels were determined as ratio of target gene vs. reference gene and were cal-
culated according to the ΔCt method [17] using the following equation:
Ratio ¼ ðEtargetÞ
Cttarget ðcontrolsampleÞ
ðEreferenceÞCtreferenceðcontrolsampleÞ
Where E is the amplification efficiency and Ct is the number of PCR cycles needed for the
signal to exceed a predetermined threshold value. Dual internal reference genes (GAPDH
and β-actin) were incorporated in all qPCR experiments and results were similar following
standardization to either gene. For each sample a controls that was not treated with reverse
transcriptase was included and no amplification above background levels was observed.
Non-template controls were included for each gene in each run and no amplification above
background levels was observed. Specificity of the amplification was ensured by checking the
melting temperature and profile of each melting curve. The product of each template was
checked at least once by sequencing.
Mouse BMDCs assays
Mouse BMDCs from BALB/c mice were prepared as previously described [18]. Briefly, bone
marrow cells isolated from femurs and tibias were seeded at 2 x 105 cells/ml in bacteriological
Petri dishes in RPMI 1640 medium containing 10% fetal bovine serum, 150 μg/ml gentamycin
and 20 ng/ml mouse rGMCSF (Sigma-Aldrich, Munich, Germany). Fresh medium was added at
day 3 and 6 and BMDCwere used on day 8 of culture. Where indicated BMDCs (106 cells/ml)
were incubated with anti-TLR2 antibody (InvivoGen) or control isotype antibody IgG2a
(eBioscience, San Diego, CA) at concentration 10 μg/ml for 1 hour 37°C prior to stimulation
with L. plantarum, EPM or L. plantarum together with EPM for 20 h. L. plantarum was used at a
bacterium: DC ratio of 10:1, EPM at 1.2% v/v. Culture supernatants of stimulated BMDC were
stored at -20°C until use.
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Cytokine analysis
Cytokines concentrations in the hDC culture supernatants were determined using Cytokine
bead arrays (BD) and a flow cytometer (FACS Canto II, BD). In hDCs studies, the limits of de-
tection were the following: for IL-1β 7.2 pg/ml, for IL-10 3.3 pg/ml, for TNF 3.7 pg/ml and for
IL-12p70 1.9 pg/ml. Mouse IL-10 was measured in culture supernatants by enzyme-linked im-
munosorbent assay (ELISA) using Ready-Set-Go! Kit (eBioscience) according to manufactur-
er’s instructions. Levels of mouse IL-12p70 were measured with matched antibody pairs (BD).
Intrarectal administration of bacteria or EPM and induction of acute
ulcerative colitis
The experimental groups of 10 mice and their respective treatments are shown in Table 1. Mice
from groups 2, 3, 4 and 5 received 2.5% DSS (molecular weight 40 kDa; ICN Biomedicals,
Ohio, USA) in the drinking water ad libitum for one week. Mice from the untreated control
group 1 received only drinking water. Mice from groups 3 and 4 received intrarectally (via tub-
ing) daily doses of 2 to 3 x 109 CFU of F. prausnitziiHTF-F and A2-165, respectively in 100 μl
PBS for ten days prior the DSS exposure and during the eight days of DSS treatment. Mice
from group 5 received intrarectally daily doses of 50 μg the EPM in 100 μl PBS for ten days
prior the DSS exposure and during the eight days of DSS treatment. Mice from the colitis con-
trol group received intrarectally 100 μl PBS. The following clinical symptoms were measured
or assessed: firmness of faeces, rectal prolapses, rectal bleeding and colon length after the sacri-
fice. The colon descendens was taken for myeloperoxidase assay, isolation of mRNA, histologi-
cal assessment and for intestinal fragment cultivation.
Disease activity index
Disease activity index (DAI), measured according to Cooper et al. [19], is a combined score of
weight loss, stool consistency and bleeding divided by 3. Acute clinical symptoms are diarrhoea
and/or grossly bloody stools. The scores are explained in Table 2.
Table 1. DSS-induced colitis experimental groups.
Group Intrarectal treatment DSS
1 PBS -
2 PBS +
3 F. prausnitzii HTF-F +
4 F. prausnitzii A2-165 +
5 EPM +
doi:10.1371/journal.pone.0123013.t001
Table 2. Scoring of DAI (modified according to Cooper et al. 1993).
Score Weight loss Stool consistency* Occult/gross bleeding
0 None Normal Normal
1 1–5% Normal Normal
2 5–10% Loose Hemacult +
3 1–20% Loose Blood in colon, starting bleeding from anus
4 > 20% Diarrhoea Gross bleeding
* Normal stools, well-formed pellets; loose stools, pasty and semi-formed stools which do not stick to the anus; diarrhoea, liquid stools that stick to
the anus.
doi:10.1371/journal.pone.0123013.t002
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Histological evaluation of colon damage
Colon tissue was fixed in Carnoy’s fluid for 30 min, transferred into 96% ethanol and embed-
ded in paraffin. Five-mm paraffin-embedded sections were cut and stained with haematoxylin
and eosin (H&E) and Alcian Blue and poststained with NuclearFastRed (Vector, Burlingame,
CA) for mucin production. Samples were examined using an Olympus BX 40 microscope
equipped with an Olympus Camedia DP 70 digital camera, and the images were analysed using
Olympus DP-Soft. The degree of damage to the surface epithelium, crypt distortion and mucin
production in individual colon segments were evaluated according to Cooper et al. [19].
Measurement of cytokine production in colonic fragments
Pre-weighted colonic fragments were cultured in RPMI medium enriched with 10% bovine
serum albumin in 5% CO2 and 95% air at 37°C, in 24-well flat-bottomed plates (Nunc) for
48h. Culture supernatants were harvested for analysis of their cytokine content by the MILLI-
PLEX MAPMouse Cytokine/Chemokine Panel (Millipore, Schwalbach, Germany) according
to manufacturer’s instructions and analysed with the Bio-Plex System (Bio-Rad, Paris, France).
Statistics
Data were analysed using the GraphPad PRISM (Graphpad software, San Diego, CA) by one
way Anova followed by Dunnett’s multiple comparison test for the in vitro assays or by the
Tukey’s test for the in vivo assays. Gene expression levels in time and mice body weight changes
in time were compared using two way Anova followed by Bonferroni’s test.
Results
Phenotypic characteristics of F. prausnitzii strain HTF-F and purification
of the extracellular polymeric matrix
F. prausnitziiHTF-F and A2-165 form colonies with mucoid appearance on solid agar, howev-
er, only strain HTF-F forms a mucoid biofilm in liquid culture (Fig 1A). This phenotype is
commonly associated with the production of extracellular polysaccharides and intercellular ag-
gregating proteins [20]. The EPM of strain HTF-F is revealed by Gram staining (Fig 1B) and is
observed in transmission electron micrographs as a diffuse and irregular surface layer (Fig 2A,
arrow) resembling the capsule polysaccharide (CPS) of Streptococcus suis (Fig 2B [21]). The
cell bound the EPM produced by strain HTF-F was isolated, concentrated and filtered to re-
move possible bacterial contaminants. Luciferase-based TLR signalling assays for human
TLR2, TLR2/6, TLR4 and TLR5 indicated that MAMPs were not present in amounts that
would influence the activation of immune cells in vitro (S1 Fig). This was confirmed by the fact
that the EPM did not induce cytokine secretion or expression of maturation and activation
markers after incubation with hDCs (Fig 3A and 3B).
The EPM of F. prausnitzii HTF-F decreases transcription and production
of pro-inflammatory IL-12p70 in L. plantarum-activated hDCs
The immunomodulatory properties of F. prausnitzii A2-165, HTF-F and the EPM were tested
in vitro using human monocyte-derived DCs (hDCs). DCs were chosen because they are one of
the most important antigen presenting cells with the capacity to prime naive T cells at mucosal
sites and to drive the immune response. Incubation of hDCs with F. prausnitzii A2-165 and
HTF-F induced large amounts of IL-10 and small amounts of IL-12p70 compared with incuba-
tion with L. plantarum (Fig 3A) or other lactobacilli (not shown). The amount of IL-10
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produced after incubation of hDCs with strain HTF-F was lower than with strain A2-165 (Fig
3A). In these experiments, live bacteria were used but they were rapidly killed by the presence
of antibiotics in the culture medium, this is necessary to prevent bacterial overgrowth. Contact
of bacteria with DCs and phagocytosis occurs quite rapidly (30 min to 1h) so bacteria are not
very different to their live counterparts in vivo.
The EPM alone had no effect on the expression of activation or maturation markers and cy-
tokine expression compared to untreated hDCs (Fig 3B) confirming the lack of TLR signalling
activity (S1 Fig). Therefore, the EPM was combined with L. plantarum in hDC cultures to in-
vestigate whether it would modulate cytokine production. In combination with L. plantarum,
the EPM reduced the secretion of pro-inflammatory IL-12p70 but had no effect on production
of IL-10, which appeared not to be induced by L. plantarum in hDCs (Fig 3A). Cytokines IL-1β
and TNF-α were elicited by incubation of hDCs with L. plantarum but were unaffected by ad-
dition of EPM (not shown). The effect of EPM on IL-12p70 production by L. plantarum-stimu-
lated hDCs was not due to altered maturation and activation as evidenced by the measurement
of the co-stimulatory molecules CD83 and CD86 (Fig 3B). To investigate whether the reduced
secretion of IL-12p70 was due to transcriptional regulation, quantitative RT-PCR was per-
formed on IL-10, IL-12, IL-1β and TNF-αmRNA extracted from hDCs at 6 and 20 h after
Fig 1. Phenotypic characteristics of F. prausnitzii strain HTF-F and A2-165. a) Growth and biofilm
formation of F. prausnitzii strains HTF-F and A2-165 in YCFAGmedium under anaerobic conditions. i and ii)
F. prausnitzii A2-165 before and after shaking respectively; iii and iv) F. prausnitziiHTF-F before and after
shaking respectively. b) Gram staining of F. prausnitzii A2-165 (left panel) and HTF-F (right panel).
doi:10.1371/journal.pone.0123013.g001
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incubation with L. plantarum, L. plantarum combined with the EPM, EPM alone or unstimu-
lated hDCs. The addition of the EPM had no significant effect on transcription of IL-1β, TNF-
α or IL-10 in hDCs stimulated with L. plantarum (not shown) but significantly decreased the
transcript levels of IL-12 at 20h by about 2 fold (Fig 4).
The immunomodulatory effects of the EPM are TLR2 dependent
To investigate the anti-inflammatory effects of the EPM on IL-12p70 production by hDCs,
we performed an experiment using mouse bone marrow-derived DCs (BMDCs) stimulated
with L. plantarum with or without the EPM. As found using hDCs, the presence of the EPM
reduced the secretion of pro-inflammatory IL-12p70 by mouse BMDCs stimulated with L.
plantarum. Strikingly, the EPM also increased the production of IL-10 in BMDCs stimulated
with L. plantarum which was already induced at much higher levels than in hDCs stimulated
with L. plantarum. These effects were not due to the induction of cytokine secretion by the
EPM alone (Fig 5A). Additionally, we tested whether the immunomodulatory effects of the
Fig 2. Detection of F. prausnitziiHTF-F EPM by transmission electronmicroscopy. F. prausnitzii HTF-F
(a) possess a diffuse and irregular surface layer (arrow) which is thinner but similar to the capsule
polysaccharide (CPS) of S. suiswild type strain (arrow, S. suis wt, left panel b) and absent in S. suisCPS
deletion mutant (S. suis Δcps, right panel b).
doi:10.1371/journal.pone.0123013.g002
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EPM were dependent on TLR2 signalling by including a TLR2 blocking antibody or an irrele-
vant antibody of the same isotype in the assays. The effects of the EPM on IL-12p70 and IL-
10 production by L. plantarum stimulated BMDCs were inhibited in the presence of TLR2
blocking antibody but not in the presence of the isotype antibody. As the EPM did not induce
TLR2 signalling, the mechanism leading to reduced transcription of IL-12p70 and increased
production of IL-10 was presumably dependent on TLR2 signalling by L. plantarum (Fig 5B).
The fact that L. plantarum could still activate immune cells and induce cytokines in the pres-
ence of a TLR2 blocking antibody could be explained by intracellular pattern recognition re-
ceptors including NLRs and other TLRs in the phagosomal compartment.
Fig 3. Cytokine secretion and surface marker expression in hDCs.Cytokine secretion and surface
marker expression in hDCs after 48 h of incubation with F. prausnitzii A2-165 (3 donors), F. prausnitzii HTF-F
(3 donors), L. plantarum (5 donors), L. plantarum + EPM (5 donors), EPM (3 donors) or left unstimulated (5
donors). a) IL-10 and IL-12p70 were measured in the supernatant of hDCs. Error bars represent SEM, *
indicates p<0.05 compared with L. plantarum treated samples. b) Percentage of CD83+ (left panel) and
CD86+ (right panel) hDCs. Error bars represent SEM, ** indicates p<0.01, n.s. indicates non-significant
compared with the control.
doi:10.1371/journal.pone.0123013.g003
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F. prausnitzii and the EPM of strain HTF-F attenuate clinical symptoms in
DSS-colitis
The potential protective effects of F. prausnitzii strains A2-165, HTF-F and EPM were assessed
in mice using the DSS-induced colitis model. The bacteria or the EPM were administered to
mice intrarectally ten days prior to DSS exposure and continuously administered daily over a
period of eight days in which DSS was given in the drinking water to induce colitis. The severity
of colitis was evaluated for individual mice in each group by measuring disease activity index
(DAI), histological damage score of the colon, body weight and colon length. F. prausnitzii A2-
165, HTF-F and EPM administration significantly decreased the DAI compared to colitis con-
trol mice which received PBS intrarectally and DSS in the drinking water, although the score
was higher than in untreated mice (Fig 6A). The histological colon damage score was grade 0
in untreated mice (Figs 6B and 7A). F. prausnitzii HTF-F administration significantly de-
creased colon damage score compared to the colitis control mice (grade 1.65 and 3.2 respec-
tively, Figs 6B, 7C and 7B), while F. prausnitzii A2-165 and EPM administration did not
significantly affect the colon damage score compared to colitis control mice (grade 2.8 and 3.3
respectively, Figs 6B, 7D and 7E).
The colon length was reduced in all DSS treated groups compared to untreated mice but the
F. prausnitziiHTF-F treated group had significantly longer colons compared with colitis con-
trol mice (Fig 6C) indicating a reduced severity of colitis. The body weight of mice was mea-
sured throughout the period of DSS treatment and compared to the weight before treatment.
In untreated mice, the body weight increased by approximately 5% from day 5 to day 8. How-
ever, in colitis control mice, the body weight decreased by approximately 5% from day 5 to day
8. In mice administered F. prausnitziiHTF-F, A2-165 or EPM, the decrease in body weight was
delayed by one day compared to the colitis control mice and for mice treated with F. prausnitzii
HTF-F or EPM the final body weight on day 8 was significantly higher than that of the colitis
control group (Fig 6D). Taken together these results indicate that F. prausnitzii strains A2-165,
HTF-F as well as the EPM can attenuate the clinical symptoms of DSS-induced colitis.
Fig 4. Relative gene expression levels in hDCs determined by quantitative RT-PCR. RNA was extracted
from hDCs after 6 and 20 h of incubation with L. plantarum (in black), L. plantarum + EPM (in dark grey), EPM
(in clear grey) or from unstimulated cells (in white) and the expression levels of IL-12p70 gene was calculated
relative to the expression levels of the housekeeping gene GAPDH. Error bars represent SEM, n = 3, ***
indicates p<0.001 compared with L. plantarum treated samples.
doi:10.1371/journal.pone.0123013.g004
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Effects of F. prausnitzii and F. prausnitzii EPM on Foxp3 expression in
mesenteric lymph nodes and spleen of DSS-treated mice
To investigate the potential role of Foxp3+ Tregs in the attenuation of DSS-induced colitis, we
measured the number of CD4+ T cells isolated from mesenteric lymph nodes (MLNs) and
spleens that express intracellular Foxp3 by fluorescence-activated cell sorting (FACS) analysis.
DSS treatment did not significantly affect the levels of Foxp3+ CD4+ T cells in the MLNs or
spleen compared to untreated mice. Administration of F. prausnitzii also had no effect on
Foxp3+ CD4+ T cells compared to untreated mice. However, administration of EPM induced a
small but significant increase in Foxp3+ CD4+ T cells in the MLNs but not in the spleen (Fig 8).
F. prausnitzii HTF-F decreases the secretion of IFN-γ and IL-17 from
colonic cultures
To investigate the effects of the treatments on cytokine secretion in the colon, sections from
colon descendens were cultured and the cytokine secretion was measured. DSS treatment sig-
nificantly increased cytokine secretion from cultures of colon descendens compared to untreat-
ed controls. Intrarectal administration of F. prausnitzii HTF-F and EPM induced a decrease in
the IFN-γ secretion and F. prausnitziiHTF-F induced a decrease in IL-17 secretion compared
Fig 5. Cytokine secretion in mouse BMDCswith and without anti-TLR2 blocking antibody. a) IL-10 and
IL-12p70 were measured in BMDC supernatants after incubation with L. plantarum, L. plantarum + EPM,
EPM and unstimulated DCs. b) IL-10 and IL-12p70 were measured after incubation of BMDCs with the same
samples as in panel (a) except that anti-TLR2 blocking antibody (anti-TLR2 Ab, dark grey bars) or an isotype
control (isotype Ab, clear grey bars) were included during the incubation period. Error bars represent SEM
(n = 3), *** indicates p<0.001, * indicates p<0.01, n.s. non-significant compared to L. plantarum
treated samples.
doi:10.1371/journal.pone.0123013.g005
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to PBS administration in the colitis control group. However, F. prausnitzii or EPM administra-
tion did not have effect on IL-4, IL-6, IL-10 or TNF-α secretion (Fig 9).
Discussion
In this study, we demonstrated that F. prausnitzii strain A2-165, the biofilm forming strain
HTF-F as well as the EPM isolated from strain HTF-F can attenuate the clinical symptoms of
DSS-induced colitis. Strain HTF-F was stronger than strain A2-165 or the EPM in suppress-
ing inflammation having significant effects on the colon damage score and colon length com-
pared to the other treatments (Fig 6). The administration of purified EPM decreased the DAI
Fig 6. Clinical symptoms of DSS-colitis. Disease activity index (DAI), colon histological damage score and
clinical evaluation of DSS treated mice. Mice were left untreated (in white) or treated with DSS during 8 days
and administered intrarectally with PBS (in black), EPM (in blue) or F. prausnitzii strains HTF-F (in red) or
strain A2-165 (in green). DAI, histological score and colon length (a, b and c respectively) were evaluated at
the end of the experiment. Mice body weight (d) was measured throughout the experiment, body weight
values are expressed as percentage of the initial value measured at day 0 before DSS administration. Error
bars represent SEM, n = 10, * indicates p<0.05, ** p<0.01, *** p<0.001 compared with the control colitis
mice that received DSS + PBS.
doi:10.1371/journal.pone.0123013.g006
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indicating that it contributes to the protective effect of strain HTF-F and may be responsible
for the stronger protection seen with strain HTF-F compared to A2-165. However, we cannot
rule out other possible strain differences, for example in colonization potential, stress
Fig 7. Histological colonic sections of DSS-treated mice.Histological cross-sectional views of colon descendens of untreated or DSS-treated mice: a)
colitis control, PBS-DSS-treated mice (damage grade 3–3.5) b) HTF-F-DSS-treated mice (damage grade 1–2.4); c) A2-165-DSS-treated mice, (damage
grade 2–3.7); d) EPM-DSS-treated mice (damage grade 2.8–3.8); e) untreated mice (damage grade 0).
doi:10.1371/journal.pone.0123013.g007
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resistance or fitness in vivo, which might contribute to the efficacy of immune suppression.
Improved survival or colonization of strain HTF-F in vivomight impact on the amount of bu-
tyrate produced in the colon. Microbially-produced butyrate is considered important for co-
lonic health, and in the prevention of colorectal cancer owing to its use as an energy source
for epithelial cells and as a modulator of oxidative stress and inflammation [22]. Moreover,
Fig 8. Foxp3 expression in mesenteric lymph nodes and spleen of DSS-treated mice. Percentage of
Foxp3+ CD4+ T cells isolated frommesenteric lymph nodes (MLNs, left panel) and spleens (right panel) of
mice untreated (in white) or treated with DSS during 8 days and administered intrarectally with PBS (in black),
EPM (in blue) or F. prausnitzii strains HTF-F or strain A2-165 (HTF-F in red and A2-165 in green,
respectively).
doi:10.1371/journal.pone.0123013.g008
Fig 9. IFN-γ and IL-17 secretion in colon cultures from DSS-treated mice.Mice were left untreated or
treated with DSS during 8 days and administered intrarectally with PBS, EPM or F. prausnitzii strains HTF-F
or A2-165. Cytokines were measured in the supernatants of 48h cultures of colonic fragments isolated from
mice. Error bars represent SEM, n = 5, * indicates p<0.05, ** p<0.01.
doi:10.1371/journal.pone.0123013.g009
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oral administration of sodium butyrate has been recently shown to attenuate inflammation in
experimental UC and be effective in therapy of UC patients [23]. Thus, increased butyrate
production may have contributed to the anti-inflammatory effects of the F. prausnitzii strains
in experimental colitis model. Previously, F. prausnitzii A2-165 and its supernatant were
shown to attenuate TNBS colitis in mice by daily intragastric administration prior to and dur-
ing the induction of colitis [7]. In the study of Sokol et al., the colons of mice treated with ei-
ther F. prausnitzii A2-165 or its supernatant had a reduced amount of IL-12p70 and an
elevated amount of IL-10 compared with the colitis control group. This is compatible with the
relatively high amount of IL-10 induced by in vitro culture of F. prausnitzii A2-165 with
hDCs (Fig 3) and PBMCs [7]. IL-10 is fundamental for the maintenance of homeostasis in the
intestine [24,25]. It is secreted by DCs as well as Foxp3+ and Foxp3- T cells in the lamina pro-
pria. Secretion of IL-10 by DCs is important for the maintenance of functional Foxp3+ Tregs
during intestinal inflammation [26]. IL-10 also inhibits the production of pro-inflammatory
cytokines such as IFN-γ, TNF-α, IL-6 and IL-12. Moreover, IL-10 was shown to play a role in
controlling pro-inflammatory responses to translocated microbes by abrogating IL-23 pro-
duction [27]. Nevertheless, differences in IL-10 produced in vitro by DCs cultured with F.
prausnitzii A2-165 and strain HTF-F cannot explain the better protection seen with HTF-F as
it induced less IL-10 than A2-165. In vitro assays indicated that the anti-inflammatory mecha-
nism of the EPM was not due to contamination with MAMPs or activation of DCs. However,
when the EPM was added together with L. plantarum as an inflammatory stimulus to hDCs,
it decreased the production of IL-12p70 compared to L. plantarum alone and had no effect on
IL-10, IL-1β and TNF-α production (Fig 3). A similar effect of the EPM was seen on IL-12p70
production by mouse BMDCs but, in addition, IL-10 was significantly increased (Fig 5). The
effect of EPM on IL-12p70 production occurred at the transcriptional level (Fig 4) suggesting
the involvement of the EPM in cell signalling. This mechanism was dependent on TLR2 sig-
nalling although the EPM itself did not induce TLR2 signalling in reporter assays, or activate
hDCs or mouse BMDCs as in the case of synthetic TLR2 agonists (Fig 5). L. plantarum alone
still induced cytokines in the presence of the TLR2 blocking antibody, this is most likely due
to intracellular pattern recognition signalling after phagocytosis. The mechanism of action of
the EPM may involve interaction of carbohydrate structures of the EPM with C-type lectin re-
ceptors, some of which are known to modulate cytokine production in response to TLR ago-
nists. In the DSS colitis model, administration of EPM but not F. prausnitzii increased the
number of Foxp3+ T cells in the MLNs. Similarly, the extracellular polysaccharide A of Bacter-
oides fragilis [9], has also been shown to expand the number of mucosal Foxp3+ T cells and
confers a TLR2-dependent protection in mouse colitis models [8,9]. In summary, we demon-
strated the anti-inflammatory effect of two different F. prausnitzii strains in the mouse DSS
colitis model. Furthermore, we showed that the anti-inflammatory effect of the biofilm form-
ing strain F. prausnitzii HTF-F may in part be due to the immune-regulating properties of the
EPM. In vitro immune assays suggest that the immunomodulatory effects of the EPM on IL-
10 and IL-12 cytokine production in antigen presenting cells are mediated through modula-
tion of TLR2 signalling. However, the precise anti-inflammatory mechanism of EPM awaits
identification of the active component. The newly described strain F. prausnitziiHTF-F and
the EPM may have a therapeutic use in IBD.
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